Electrochemical measurements show dual-imidazoline quaternary ammonium salt improves corrosion inhibition in N80 carbon steel, suggesting its potential in industrial applications.
A novel dual-imidazoline ring quaternary ammonium salt corrosion inhibitor (TN-IM) was rationally synthesized via a three-step sequential reaction, using hydroxyethyl ethylenediamine and tetradecanedioic acid as starting materials, with benzyl chloride as the quaternizing reagent. The synthetic process involved amidation at 160 °C for 4 h, cyclization at 220 °C for 3 h, and quaternization at 70 °C for 3 h, respectively. Fourier transform infrared spectroscopy and proton nuclear magnetic resonance were employed to characterize the chemical structure of TN-IM, confirming its successful synthesis. The corrosion inhibition performance of TN-IM was evaluated by the static weight loss method and electrochemical measurements, while the corrosion products and surface morphology of N80 carbon steel were analyzed via energy-dispersive X-ray spectroscopy and scanning electron microscopy. Static weight loss tests conducted in 3.5 wt% of a NaCl solution saturated with 0.6 MPa CO2 at 60 °C for 24 h revealed that TN-IM at a concentration of 0.15 mmol/L exhibited a corrosion inhibition efficiency 1.86% higher than that of a single-imidazoline ring quaternary ammonium salt inhibitor. Potentiodynamic polarization measurements demonstrated that TN-IM functions as a mixed-type corrosion inhibitor, with a predominant inhibitory effect on the anodic reaction on N80 steel. Electrochemical impedance spectroscopy results indicated that TN-IM molecules can adsorb onto the active sites of the N80 surface, thereby retarding the corrosion process by suppressing the charge transfer step in the electrochemical corrosion reaction. This study establishes a new paradigm for the synthesis of high-efficiency imidazoline-based CO2 corrosion inhibitors with multiple adsorption sites, holding significant implications for corrosion control in harsh industrial environments.
No takes yet. Share an insight, caveat, or question.
Qin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: